Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-11

Clinical Trial Update: Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency Department [NA]

View source ↗

Summary

A clinical trial investigating ketamine infusion for acute pain in sickle cell crisis in the emergency department has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Billy Sin | Conditions: Pain, Sickle Cell Disorder | NA | Status: TERMINATED